RBM15 and gastric adenocarcinoma: Since the hazard ratio (HR) of RBM15, DNMT1, WDR4 and ALYREF was all less than 1 (Fig. 2A), above results indicated that RBM15, DNMT1, WDR4 and ALYREF were protective factors in influencing the survival of STAD patients.